In our RPPA on bulk leukemia cells in 511 newly diagnoses AML cases we observe that PU.1 expression was very heterogeneous in expression, with 30% of cases being above that of normal CD34+ cells and 26% being lower than normal CD34+ cells (data not shown). Here, CD34 is linked to leukemia.